August 28, 2016 4:45 PM ET

Biotechnology

Company Overview of Cyclacel Pharmaceuticals, Inc.

Executive Profile

Kenneth R. Harrap CBE, Ph.D., DSc, FRSC, SAB

Member of Scientific Advisory Board, Cyclacel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Prof. Kenneth R. Harrap, CBE Ph.D. DSc FRSC SAB, served as Clinical and Scientific Advisor at Twinstrand Therapeutics, Inc. Prof. Harrap served as Director of the CRC Centre for Cancer Therapeutics, a multidisciplinary unit responsible for the discovery and development of new anticancer drugs, at the institute of Cancer Research, Sutton, United Kingdom until September 1997. He has formed collaborations with the pharmaceutical industry that have led to the clinical development, ...

Corporate Headquarters

200 Connell Drive
Berkeley Heights, New Jersey 07922

United States

Phone: 908-517-7330
Fax: 866-271-3466

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD 1961
University Of London
ScD 1997
University Of London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cyclacel Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.